| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
9e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-09 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-08 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |